This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Celleron Therapeutics Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Simon Cook - Innovator in Anti-Inflammatory Treatments
Introduction
Simon Cook is a notable inventor based in Oxford, GB. He has made significant contributions to the field of medicine, particularly in the treatment of inflammatory diseases. His innovative work has led to the development of a unique pharmaceutical compound aimed at addressing critical health issues.
Latest Patents
Simon Cook holds a patent for the treatment of inflammatory disease. The patent details the use of N-(2-aminophenyl)-4-(1-[(1,3-dimethyl-1H-pyrazol-4-yl)methyl]piperidin-4-yl)benzamide (CXD101), or a pharmaceutically acceptable salt thereof, as an anti-inflammatory agent. This invention is particularly focused on the treatment of immune checkpoint inhibitor-induced colitis, showcasing its potential impact on patient care.
Career Highlights
Simon Cook is associated with Celleron Therapeutics Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for patients suffering from inflammatory conditions.
Collaborations
Simon collaborates with esteemed colleagues, including David Kerr and Nicholas La Thangue. Their combined expertise enhances the research and development process, fostering innovation in the pharmaceutical industry.
Conclusion
Simon Cook's contributions to the field of anti-inflammatory treatments exemplify the importance of innovation in medicine. His patent and ongoing work at Celleron Therapeutics Limited highlight his dedication to improving health outcomes for patients.